ArticleESMO gastrointestinal oncology2025

The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy.

S Udagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.